Radcliffe Capital Management, L.P. - EUCRATES BIOMEDICAL ACQU COR ownership

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$1,205
-99.6%
33,3330.0%0.00%
-100.0%
Q4 2022$332,997
-0.3%
33,3330.0%0.01%
+37.5%
Q3 2022$334,000
+1.2%
33,3330.0%0.01%0.0%
Q2 2022$330,000
+0.3%
33,3330.0%0.01%
+14.3%
Q1 2022$329,000
+1.2%
33,3330.0%0.01%
-22.2%
Q4 2021$325,000
-0.3%
33,3330.0%0.01%0.0%
Q3 2021$326,000
-0.6%
33,3330.0%0.01%
-10.0%
Q2 2021$328,000
-1.5%
33,3330.0%0.01%
-23.1%
Q1 2021$333,000
-0.6%
33,3330.0%0.01%
-38.1%
Q4 2020$335,00033,3330.02%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 66,666$651,0000.02%
Altium Capital Management LP 133,333$77,0000.02%
Granite Point Capital Management, L.P. 133,332$77,0000.01%
AQR Arbitrage LLC 45,832$447,0000.01%
Radcliffe Capital Management, L.P. 33,333$325,0000.01%
COWEN AND COMPANY, LLC 178,347$103,0000.01%
CVI Holdings, LLC 118,333$69,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 333,333$193,0000.00%
KINGDON CAPITAL MANAGEMENT, L.L.C. 66,665$36,0000.00%
683 Capital Management, LLC 200,000$116,0000.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders